New research has found a potential link between semaglutide use and a rare eye condition called NAION, though more work is needed to prove causation.
Dozens of obesity and diabetes treatments are in the pipeline, some of which may help people lose even more weight than existing drugs like semaglutide.
The UN agency has received reports of medication falsified to look like the diabetes and weight loss drug Ozempic in at least 3 countries, including the U.S.
Critics claim that drugs like semaglutide and other GLP-1s can dangerously sap away our muscle mass, but what does the current science actually tell us?
New research is the latest to link the use of Ozempic, Wegovy, and other GLP-1 drugs to a greater risk of gastroparesis. Here's what we know so far.
The telehealth company's stock surged after the announcement
The results of the longest-running trial of semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, are here and looking positive.
Users are being told to closely monitor their insulin pump battery levels before bed.
In a new small trial of an experimental procedure, patients lost about 8% of their baseline weight and experienced a significant drop in their hunger.
The Vermont senator is launching an investigation into why these game-changing diabetes and obesity drugs can cost more than $1,000 a month in America.
Ozempic and other weight loss drugs are coming for the alcohol and tobacco industries next
Some people fear that new obesity drugs will inevitably prove to be dangerous, but there are key distinctions from the fen-phen crisis of the 1990s.
It's the second recent investigation by health regulators to clear GLP-1 drugs of causing suicidal thoughts.
Roughly 42% of Americans are obese, making the U.S. a huge market for anti-obesity drugs.
In a new Oscar-themed commercial, the drugmaker is telling people to stay away from its blockbuster medications if they’re only looking to lose a few pounds.
A study suggests that GLP-1 drugs, already used to treat diabetes and obesity, could also tamp down cravings for opioids.
Patients who took GLP-1 drugs were less likely to be diagnosed with depression and anxiety afterward compared to non-users.
Zepbound (tirzepatide) had striking effects on blood pressure in the latest trial data, in addition to helping people shed pounds.
More than a third of former semaglutide regained their shed pounds, however.
The FDA said it has "not found evidence that use of these medicines causes suicidal thoughts or actions" though it's still investigating the matter.
